Type 2 diabetes and cognitive impairment: a case for screening?

Abstract There have been many concerns raised regarding whole‐population screening for dementia. Targeting higher risk groups, such as those with type 2 diabetes, may be more clinically meaningful, argue Hannah Price and Andrew Larner.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fpnp.296

Source: Progress in Neurology and Psychiatry - October 8, 2013 Category: Neurology Authors: Hannah L Price, Andrew J Larner Tags: Opinion Source Type: research